Literature DB >> 11179103

Sildenafil modulates hemodynamics and pulmonary gas exchange.

A Kleinsasser1, A Loeckinger, C Hoermann, F Puehringer, N Mutz, G Bartsch, K H Lindner.   

Abstract

The effects of sildenafil (Viagra) on hemodynamics and pulmonary gas exchange remain uncertain. The aim of this study was to investigate what effect sildenafil had on gas exchange. A total of 24 anesthetized pigs were randomly assigned into four groups of six animals each: Group Low received 25 mg of sildenafil, which is equivalent to half the recommended dose for humans; group Normal received 50 mg; group High received 100 mg; and one group served as control. Inert gas and hemodynamic measurements were performed to define dose-dependent effects of sildenafil on cardiac and pulmonary function. Measurements were taken 30, 60, and 90 min after the administration of sildenafil via gastric tube. All doses of sildenafil caused significant increases in intrapulmonary shunt flow (maximum amplitude, 4.4 +/- 0.3 to 11.9 +/- 0.5%; mean +/- SEM), which was reflected by marked decreases in PaO2. Sildenafil elicited some significant increases in cardiac index (CI) (high dose, 142 +/- 10 to 196 +/- 13 ml x kg(-1), mean +/- SEM). Mean arterial pressure was significantly depressed after the high dose of sildenafil. Pulmonary artery pressure was decreased after high-dose sildenafil (maximum amplitude, 16 +/- 1.6 to 14 +/- 1.8, mean +/- SEM). No significant differences between the three treatment groups were found. Sildenafil represents and orally active substance with phosphodiesterase V inhibitory and cardiac output-increasing actions. PaO2 decrease after 50 and 100 mg of sildenafil was observed in the presence of significant rises in pulmonary shunt flow and CI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179103     DOI: 10.1164/ajrccm.163.2.2003021

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

Review 1.  [Respiratory system at high altitude: pathophysiology and novel therapy options].

Authors:  Suzan S Trübsbach; Iris Pircher; Benedict Treml; Alex Löckinger; Axel T Kleinsasser
Journal:  Wien Klin Wochenschr       Date:  2011-02-16       Impact factor: 1.704

Review 2.  Ventilation/Perfusion Matching: Of Myths, Mice, and Men.

Authors:  Alys R Clark; Kelly S Burrowes; Merryn H Tawhai
Journal:  Physiology (Bethesda)       Date:  2019-11-01

3.  Aggravation of hepatopulmonary syndrome after sildenafil treatment in a patient with coexisting portopulmonary hypertension.

Authors:  Seungmin Chung; Kyungho Lee; Sung-A Chang; Duk-Kyung Kim
Journal:  Korean Circ J       Date:  2015-01-26       Impact factor: 3.243

Review 4.  Safety of sildenafil in infants*.

Authors:  Samira Samiee-Zafarghandy; P Brian Smith; Johannes N van den Anker
Journal:  Pediatr Crit Care Med       Date:  2014-05       Impact factor: 3.624

5.  Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration.

Authors:  Ralf Geiger; Axel Kleinsasser; Stephan Meier; Nikolaus Neu; Werner Pajk; Victoria Fischer; Benedict Treml; Joerg I Stein; Alexander Loeckinger
Journal:  Intensive Care Med       Date:  2007-09-27       Impact factor: 17.440

6.  Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery.

Authors:  Christian Stocker; Daniel J Penny; Christian P Brizard; Andrew D Cochrane; Rodrigo Soto; Lara S Shekerdemian
Journal:  Intensive Care Med       Date:  2003-10-07       Impact factor: 17.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.